Dext

rose

5%

Sodi

um C

hlor

ide

Acyc

lovi

r

Amik

acin

Amio

daro

ne

Azith

rom

ycin

Aztre

onam

Bum

etan

ide

Calc

ium

chl

orid

e

Calc

ium

glu

cona

te

Cefa

zolin

Cefe

pim

e

Ceftr

iaxo

ne

Cim

etid

ine

Cipr

oflo

xaci

n

Cisa

tracu

rium

Dexa

met

haso

ne

Digo

xin

Dilti

azem

Diph

enhy

dram

ine

Dobu

tam

ine

Dopa

min

e

Enal

april

Epin

ephr

ine

Esm

olol

Fam

otid

ine

Fent

anyl

Fluc

onaz

ole

Furo

sem

ide

Gent

amic

in

Hepa

rin

Hydr

ocor

tison

e

Hydr

omor

phon

e

Imip

enem

Insu

lin, R

egul

ar

Keto

rola

c

Labe

talo

l

Lans

opra

zole

Levo

floxa

cin

Line

zolid

Lore

zepa

m

Mag

nesi

um S

O 4

Man

nito

l

Mer

open

em

Met

hylp

redn

isol

one

Met

oclo

pram

ide

Met

opro

lol

Met

roni

dazo

le

Mid

azol

am

Milr

inon

e

Mor

phin

e

Mul

tivita

min

s

Nitro

glyc

erin

Nitro

prus

side

Nore

pine

phrin

e

Onda

nset

ron

Pant

opra

zole

Phen

ylep

hrin

e

Pipe

raci

llin/

Tazo

bact

am

Pota

ssiu

m C

hlor

ide

Prop

ofol

Rani

tidin

e

Sodi

um B

icar

bona

te

Tobr

amyc

in

Vanc

omyc

in

Vaso

pres

sin

Vecu

roni

um

AcyclovirAmikacinAmiodaroneAzithromycinAztreonamBumetanideCalcium chlorideCalcium gluconateCefazolinCefepimeCeftriaxoneCimetidineCiprofloxacinCisatracuriumDexamethasoneDigoxinDiltiazemDiphenhydramineDobutamineDopamineEnalaprilEpinephrineEsmololFamotidineFentanylFluconazoleFurosemideGentamicinHeparinHydrocortisoneHydromorphoneImipenemInsulin, Regular

CCCCCCCCCCCCCCCCCCCCCCCCCCNCCCCNC

CCNCCCCCCCCCCCCCCCCCCCCCCNCCCCCCC

—CNNICNCCICCICCNNCIICIICCCCCCCCCC

C—CICCCCCCCICCCNCCCCCCCCCCCCICCCN

NC—NNCCCNNCNCNNICNCCNCCCCCNCINNIC

NIN—INNNNNININNNNCNNNNNIINIINNNIN

ICNI

—CNCCCCCCCCNCNCCCCCCCCCCCCCNC

CCCNC—NNCCCNNCCNCCNCCCCCCCCCCCCCC

NCCNNN—NNNNNNNNNNNCCNCCNNNNNNCNNN

CCCNCNN—CCINCCINCCNCCCCCCNCCCNCNC

CCNNCCNC—NCNNICNCIIICCCNCCCNCCNCC

ICNNCCNCN—NNINCNIIIIINNINCCNCCCCC

CCCICCNICN—NNCCNCIICCCCNCNCNCCCIC

CINNCNNNNNN—NCCCCCCNCCCNCCCNCNCNN

ICCICNNCNINN—CICCCCCNNNNNCICIICNN

CCNNCCNCINCCC—CCCCCCCCCCCCICICCCN

CCNNCCNICCCCIC—NCIICCCICCCCICCNCC

NNINNNNNNNNCCCN—CNINNNCCCINNCNNNC

NCCNCCNCCICCCCCC—CCCCCCCCCICNNCCI

CCNCNCNCIIICCCINC—CCCCCCCCICNNCCI

ICCNCNCNIIICCCIICC—CCCCCCCICIICNI

ICCNCCCCIICNCCCNCCC—CCCCCCICCCCCN

CCNNCCNCCICCNCCNCCCC—CCCCCCCCCCCC

ICCNCCCCCNCCNCCNCCCCC—CCCCCCCCCCN

ICCNCCCCCNCCNCICCCCCCC—CCCICNNCCC

CCCICCNCNINNNCCCCCCCCCC—CCICCCCCN

CCCICCNCCNCCNCCCCCCCCCCC—CCCCCCCC

CCCNCCNNCCNCCCCICCCCCCCCC—ICCCCIC

CCNICCNCCCCCIICNIIIICCIICI

—ICCCCC

CCCICCNCNNNNCCINCCCCCCCCCCI

—IICCN

CIINCCNCCCCCIICCNNICCCNCCCCI

—NNCC

CCNNCCCNCCCNICCNNNICCCNCCCCIN—CCC

CCNNCCNCNCCCCCNNCCCCCCCCCCCCNC—CC

CCIINCNNCCINNCCNCCNCCCCCCICCCCC—C

CNCNCCNCCCCNNNCCIIINCNCNCCCNCCCC—

NNNINNNNNNNNNCCNNNNNNNNNCNNNNNCNN

ICCNCCNCNNICNNINCCCCCCCCCCNCNICCI

NCNNINNIIICNINCNIIIIINIICCICCIIIN

ICIICCNCICCCNNCNCCCCCCCCCCICICCCI

CCCNCCNCCCNCCCCCCCCCCCCCCCCCCCCCC

CCCNICNCCCCCCCCNCCCCCCCCCCCCCCCIC

CCNNCCICNIINICCNCCNCCCCCCCNCCNCCC

CCNNCCNCCICNNCCNCCCCCCCCCCCCCCCIC

INNNNNNCNNNCNNCCCCCCCNNNNCCCCNCNC

CCCNCCNICCCCIICNIICCCCNCCCCCCNCCC

CCNNCCNNCICNCCCNCCCCCCCCCCICCCCCC

NNNNNNNNNNNCNNNNNNNNNNNNNNNNNNNNN

CCNNINNNCCCCCCNNCNNCCNCNNCNNCCCNN

ICCNCINCCICCCCICCCICCCCCCCICCICIN

CCCNNCCCCCNCCNCCCNCCCCNNCNICCNCIC

ICCICCCCCICCNCCCCCCCCCCCCCICNNCCN

NNNNNNCNINNNNNCNNNNNNCNNNNNCNNNNN

CCCNCCNCCNCNNCCNCCCCCCCCCCCCCCCCC

ICNNCCCCCNCCNICNCINCCCCCCCCCCCCNC

NCCNCCCCCNCNCCCNCCCCCCCCCCNCCCCCI

ICNCCCNCCINCCCCNCCCCCCCCCCICCCCCN

NNNCICINNICNININIIINNNIIIINNNNNCN

ICCNCCNCCNCNNCCNCCCCCCCCCCNCCCCCI

ICIICCNCNCNCICCNICICCCCICCCNCCCNI

CCCICCICCCCCCCCCCCCCCCCCCCCCCCCNC

CINNCCICCNCCIICINCCCCCCCCCCICCCCC

CCNNCNNNCCNNCCNCCNCCCCCNCCCCCNCNI

CCINCCIICCCNICCNIIIICICCCCCCCCIIC

CCCICCNCNNINCCINCCCCCCCCCCCCINCCN

CCCNNCNCNNNCNCNNCCCCCCCCCCICINCCC

NCCNCCNCCNCNCNCNCCCCCCCCCCNCCCNCN

NNCNNNNNCNNCNNNNCNCCNCCNCCICCCCNN

IV Compatibilities The IV compatibility table provides data when 2 or more medications are given into a Y-site of administration. The data in this table largely represent physical incompatibilities (e.g., haze, precipitate, change in color). Therapeutic incompatibilities have not been included, so when using the table, professional judgment should be exercised.

C Ph

ysic

ally

com

patib

le v

ia Y

-site

adm

inis

trat

ion.

I

Phys

ical

ly in

com

patib

le.

N In

form

atio

n on

com

patib

ility

not

ava

ilabl

e or

con

fl ict

ing

Dext

rose

5%

Sodi

um C

hlor

ide

Acyc

lovi

r

Amik

acin

Amio

daro

ne

Azith

rom

ycin

Aztre

onam

Bum

etan

ide

Calc

ium

chl

orid

e

Calc

ium

glu

cona

te

Cefa

zolin

Cefe

pim

e

Ceftr

iaxo

ne

Cim

etid

ine

Cipr

oflo

xaci

n

Cisa

tracu

rium

Dexa

met

haso

ne

Digo

xin

Dilti

azem

Diph

enhy

dram

ine

Dobu

tam

ine

Dopa

min

e

Enal

april

Epin

ephr

ine

Esm

olol

Fam

otid

ine

Fent

anyl

Fluc

onaz

ole

Furo

sem

ide

Gent

amic

in

Hepa

rin

Hydr

ocor

tison

e

Hydr

omor

phon

e

Imip

enem

Insu

lin, R

egul

ar

Keto

rola

c

Labe

talo

l

Lans

opra

zole

Levo

floxa

cin

Line

zolid

Lore

zepa

m

Mag

nesi

um S

O 4

Man

nito

l

Mer

open

em

Met

hylp

redn

isol

one

Met

oclo

pram

ide

Met

opro

lol

Met

roni

dazo

le

Mid

azol

am

Milr

inon

e

Mor

phin

e

Mul

tivita

min

s

Nitro

glyc

erin

Nitro

prus

side

Nore

pine

phrin

e

Onda

nset

ron

Pant

opra

zole

Phen

ylep

hrin

e

Pipe

raci

llin/

Tazo

bact

am

Pota

ssiu

m C

hlor

ide

Prop

ofol

Rani

tidin

e

Sodi

um B

icar

bona

te

Tobr

amyc

in

Vanc

omyc

in

Vaso

pres

sin

Vecu

roni

um

KetorolacLabetalolLansoprazoleLevofloxacinLinezolidLorazepamMagnesium SO4

MannitolMeropenemMethylprednisoloneMetoclopramideMetoprololMetronidazoleMidazolamMilrinoneMorphineMultivitaminsNitroglycerinNitroprussideNorepinephrineOndansetronPantoprazolePhenylephrinePiperacillin/TazobactamPotassium ChloridePropofolRantidineSodium BicarbonateTobramycinVancomycinVasopressinVecuronium

CCCCCCCCICCCCCCCCCCCCCCCCCCCCCCC

CCCCCCCCCCCCCCCCCCCNCCCCCNCCCCCC

NINICCCCICCNCICINCININIICCCCCCNN

NCCCCCCCNCCNCCCCNCCCCNCCCICCCCCN

NCNICCNNNCNNNCCCNCNCNNCICNNICCCC

INNINNNNNNNNNNNINNNNCCNIINNNINNN

NCICCICCNCCNICNCNCCCCICCCCCCCNCN

NCNCCCCCNCCNNICCNCCCCCCCCCNCCCCN

NNNNNNINNNNNNNCCCNCCNINNIININNNN

NCICCCCCCINNNCCCNCCCCNCCCCNICCCN

NNIICCNCNCCNCCCCICCCCNCNCCCCNNCC

NNICCCIINCINCICINNNNIINCCNCCNNNN

NICCNCICNCCNCCNCNCCCNCCNCCNCINCN

NCNCCCNNCCNCCCCCNNCNCNNCCCNNNCNC

NNINCCINNICNCCCNNNNCCINICICICNCN

CNNNCCCCNICNCCNCNCICCNCCCICCCCNN

CICCCCCCCCCNNICCCCCCCICCCCNCINCN

NNNNCNNNCNNNNCCCNNNNNNNNCICNNNNN

NCICCCCCCICNCCCCNCCCCICICNCICCCC

NCICCCCCCICNNCNCNCICCICCCCNICCCN

NCICCCNCCCCNNICCNCNCCICICCCICCCC

NCICCCCCCCCNCCCCNCCCCNCCCCCICCCC

NCICCCCCCCCNCCCCNCCCCNCCCCCCCCCN

NCNCCCCCNCCNNCCCCCCCCNCCCCCICCCC

NCICCCCCNNCNCCNCNCCCCICCCCCCCCCC

NCICCCCCNCCNNCNCNCCCCICICCNCCCCN

CCCCCCCCNCCNNCCCNCCCCICCCCCCCCCC

NCCCCCCCCCCNCCNCNCCCCICCCCCCCCCC

NNIICCNCCCINNIIINCCNINNCCCCCCINI

NCCCCCCCCCCNNCCCCCCCCNCNCICCCCCC

NNCICCCCCCCNCCCNNCCCCNCCCCCCIICC

NIICCCNCNNCNCINNNCCCCNCCCCNCNNCC

CCICCCCCCCCNCCCCNCCCCNCCCCCICCNC

NCICCICINCCNNIICNCNCCCCNNCNICCCN

NINICCCCCCCNNNCNNCCINNIICCICNCNN

—NNNNCNINNNNNNNCNNNNNNNNNNNNNNNN

N—ICCCCCNCCNCCCNNCCCCICICCCNCCCC

NI

—INIICNIINIINININNINICINNIIINN

NCI

—CNCNNCCNCCNCNIINCICICINCCCNN

NCNC—CCCCCCNCCNCNCCCCICCCNCCCCCC

CCINC—CCCCCNCCCCNCCCIICCCCCCCCCC

NCICCC—CCICNCCCCNCCCCNCCCCNNCCCN

ICCNCCC—ICCNNCNCICCCCNCCCCNCCCCN

NNNNCCCI

—NCNNNCCNNNCINNNNNCINCCN

NCICCCICN—CNCCCCNCCCIICCNICCCCCN

NCICCCCCCC—NNCNCCCCCCNCCCICCCCCN

NNNNNNNNNNN—NNNCNNNNNNNNNNNNNNNN

NCICCCCNNCNN—CCCNNNNNINCNNNNNNCN

NCICCCCCNCCNC—CCNCCCCICICNCICCCC

NCNNNCCNCCNNCC—CNCCCNNNCCCCCCCCC

CNICCCCCCCCCCCC—NCCCCNCCCNCNCCCC

NNNNNNNINNCNNNNN—NNCNNNNNNNNNNNN

NCIICCCCNCCNNCCCN—CCCNCCCCCCCCCC

NCNICCCCNCCNNCCCNC—CCNCCCCCCCCCC

NCNNCCCCCCCNNCCCCCC—CNCCCCCICCCC

NCICCICCIICNNCNCNCCC—ICCCCCICCCN

NINIIINNNINNIINNNNNNI

—CNCNNNNNCN

NCICCCCCNCCNNCNCNCCCCC—CCNNCCCCN

NICICCCCNCCNCICCNCCCCNC—CNCCIICN

NCICCCCCNNCNNCCCNCCCCCCC—CCCCCCN

NCNINCCCNIINNNCNNCCCCNNNC—CCINNC

NCNNCCNNCCCNNCCCNCCCCNNCCC—NNCNC

NNICCCNCICCNNICNCCCIINCCCCN—CNCN

NCICCCCCNCCNNCCCNCCCCNCICINC—CCN

NCICCCCCCCCNNCCCNCCCCNCICNCNC—CC

NCNNCCCCCCCNCCCCNCCCCCCCCNNCCC—N

NCNNCCNNNNNNNCCCNCCCNNNNNCCNNCN—

IV CompatibilitiesThe IV compatibility table provides data when 2 or more medications are given into a Y-site of administration. The data in this table largely represent physical incompatibilities (e.g., haze, precipitate, change in color). Therapeutic incompatibilities have not been included, so when using the table, professional judgment should be exercised.

C Ph

ysic

ally

com

patib

le v

ia Y

-site

adm

inis

trat

ion.

I Ph

ysic

ally

inco

mpa

tible

.N

Info

rmat

ion

on c

ompa

tibili

ty n

ot a

vaila

ble

or c

onfl i

ctin

g